VTRS stock has a consensus “Hold” rating overall ... On Dec. 6, Piper Sandler Companies (PIPR) raised Viatris' price target to $14 from $13 while maintaining a “Neutral” rating.

Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...

VTRS is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. Value investors also love the P/S ratio, which is calculated by simply dividing a stock's price with the company's ...

VTRS) today announced that on November 4, 2024, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock.